90 related articles for article (PubMed ID: 7550554)
1. Anxiolytic-like action of intra-hippocampally administered NMDA antagonists in rats.
Jessa M; Nazar M; Płaźnik A
Pol J Pharmacol; 1995; 47(1):81-4. PubMed ID: 7550554
[TBL] [Abstract][Full Text] [Related]
2. Effects of antagonists at the NMDA receptor complex in two models of anxiety.
Plaznik A; Palejko W; Nazar M; Jessa M
Eur Neuropsychopharmacol; 1994 Dec; 4(4):503-12. PubMed ID: 7894261
[TBL] [Abstract][Full Text] [Related]
3. The role of the hippocampus and 5-HT/GABA interaction in the central effects of benzodiazepine receptor ligands.
Nazar M; Siemiatkowski M; Członkowska A; Sienkiewicz-Jarosz H; Płaźnik A
J Neural Transm (Vienna); 1999; 106(5-6):369-81. PubMed ID: 10443544
[TBL] [Abstract][Full Text] [Related]
4. Anticonflict effects of a competitive NMDA receptor antagonist and a partial agonist at strychnine-insensitive glycine receptors.
Przegaliński E; Tatarczyńska E; Dereń-Wesołek A; Chojnacka-Wójcik E
Pharmacol Biochem Behav; 1996 May; 54(1):73-7. PubMed ID: 8728541
[TBL] [Abstract][Full Text] [Related]
5. NMDA receptor antagonists change behavioral activity of rats treated with (S)-4CPG.
Car H; Oksztel R; Nadlewska A; Wiśniewski K
Pol J Pharmacol; 2001; 53(4):331-9. PubMed ID: 11990079
[TBL] [Abstract][Full Text] [Related]
6. The effects of NMDA receptor antagonists at anticonvulsive doses on the performance of rats in the water maze task.
Ylinen A; Pitkänen M; Sirviö J; Hartikainen T; Sivenius J; Koivisto E; Riekkinen PJ
Eur J Pharmacol; 1995 Feb; 274(1-3):159-65. PubMed ID: 7768268
[TBL] [Abstract][Full Text] [Related]
7. Dorsal hippocampal N-methyl-D-aspartate glutamatergic and δ-opioidergic systems modulate anxiety behaviors in rats in a noninteractive manner.
Solati J
Kaohsiung J Med Sci; 2011 Nov; 27(11):485-93. PubMed ID: 22005157
[TBL] [Abstract][Full Text] [Related]
8. The behavioral effects of NMDA antagonists in serotonin depleted rats.
Płaźnik A; Jessa M; Nazar M
Pharmacol Biochem Behav; 1997 Sep; 58(1):159-66. PubMed ID: 9264085
[TBL] [Abstract][Full Text] [Related]
9. Competitive (AP7) and non-competitive (MK-801) NMDA receptor antagonists differentially alter glucose utilization in rat cortex.
Clow DW; Lee SJ; Hammer RP
Synapse; 1991 Apr; 7(4):260-8. PubMed ID: 1828310
[TBL] [Abstract][Full Text] [Related]
10. Antinociceptive effect of intra-hippocampal CA1 and dentate gyrus injection of MK801 and AP5 in the formalin test in adult male rats.
Soleimannejad E; Naghdi N; Semnanian S; Fathollahi Y; Kazemnejad A
Eur J Pharmacol; 2007 May; 562(1-2):39-46. PubMed ID: 17362915
[TBL] [Abstract][Full Text] [Related]
11. N-methyl-D-aspartate receptor antagonists are less effective in blocking long-term potentiation at apical than basal dendrites in hippocampal CA1 of awake rats.
Leung LS; Shen B
Hippocampus; 1999; 9(6):617-30. PubMed ID: 10641754
[TBL] [Abstract][Full Text] [Related]
12. Characterization of the anticonflict effect of MK-801, a non-competitive NMDA antagonist.
Söderpalm AK; Blomqvist O; Engel JA; Söderpalm B
Pharmacol Toxicol; 1995 Feb; 76(2):122-7. PubMed ID: 7746795
[TBL] [Abstract][Full Text] [Related]
13. A characterization of anxiolytic-like actions induced by the novel NMDA/glycine site antagonist, L-701,324.
Kotlinska J; Liljequist S
Psychopharmacology (Berl); 1998 Jan; 135(2):175-81. PubMed ID: 9497023
[TBL] [Abstract][Full Text] [Related]
14. Cortical epileptic afterdischarges in immature rats are differently influenced by NMDA receptor antagonists.
Slamberová R; Mares P
Eur J Pharmacol; 2005 May; 516(1):10-7. PubMed ID: 15904917
[TBL] [Abstract][Full Text] [Related]
15. Dopaminergic system in CA1 modulates MK-801 induced anxiolytic-like responses.
Zarrindast MR; Nasehi M; Pournaghshband M; Yekta BG
Pharmacol Biochem Behav; 2012 Nov; 103(1):102-10. PubMed ID: 22885281
[TBL] [Abstract][Full Text] [Related]
16. Functional antagonists at the NMDA receptor complex exhibit antidepressant actions.
Trullas R; Skolnick P
Eur J Pharmacol; 1990 Aug; 185(1):1-10. PubMed ID: 2171955
[TBL] [Abstract][Full Text] [Related]
17. The NR2B-selective N-methyl-D-aspartate receptor antagonist Ro 25-6981 [(+/-)-(R*,S*)-alpha-(4-hydroxyphenyl)-beta-methyl-4-(phenylmethyl)-1-piperidine propanol] potentiates the effect of nicotine on locomotor activity and dopamine release in the nucleus accumbens.
Kosowski AR; Liljequist S
J Pharmacol Exp Ther; 2004 Nov; 311(2):560-7. PubMed ID: 15256539
[TBL] [Abstract][Full Text] [Related]
18. A competitive antagonist of NMDA receptors CGP 40116 attenuates experimental symptoms of schizophrenia evoked by MK-801.
Zajaczkowski W; Czyrak A; Wedzony K
Pol J Pharmacol; 2003; 55(5):703-11. PubMed ID: 14704466
[TBL] [Abstract][Full Text] [Related]
19. Effects of dizocilpine-induced glutamatergic blockade in the nucleus accumbens septi on the plus maze test.
Gargiulo API; Gargiulo De Aranda MP; Gargiulo MML; Gargiulo AJM; Acuña A; Baiardi GC; Lafuente JV; Landa De Gargiulo AI; Guevara MA; Gargiulo PA
J Basic Clin Physiol Pharmacol; 2018 Jun; 29(3):241-246. PubMed ID: 29902911
[TBL] [Abstract][Full Text] [Related]
20. NMDA and not non-NMDA receptor antagonists are protective against seizures induced by homocysteine in neonatal rats.
Folbergrová J
Exp Neurol; 1994 Dec; 130(2):344-50. PubMed ID: 7867764
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
